Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 19 is a type I cytokeratin, a cytoplasmic intermediate filament protein, playing a crucial role in maintaining the structural integrity of epithelial cells. It is often used as a biomarker for detecting tumor cells, particularly in cancers like breast, lung, and stomach carcinomas. CK-19 is also involved in cancer stem cell reprogramming and modulating drug sensitivity in cancer cells.
Not applicable as it is primarily used as a biomarker rather than a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 19, also known as Cytokeratin 19 (CK-19) (CK-19).